Literature DB >> 31155284

Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification.

Elena-Raluca Nicoli1, Mary R Weston2, Mary Hackbarth1, Alissa Becerril2, Austin Larson3, Wadih M Zein4, Peter R Baker3, John Douglas Burke5, Heidi Dorward5, Mariska Davids1, Yan Huang1, David R Adams6, Patricia M Zerfas7, Dong Chen8, Thomas C Markello6, Camilo Toro6, Tim Wood9, Gene Elliott10, Mylinh Vu11, Wei Zheng11, Lisa J Garrett10, Cynthia J Tifft6, William A Gahl12, Debra L Day-Salvatore13, Joseph A Mindell14, May Christine V Malicdan15.   

Abstract

Optimal lysosome function requires maintenance of an acidic pH maintained by proton pumps in combination with a counterion transporter such as the Cl-/H+ exchanger, CLCN7 (ClC-7), encoded by CLCN7. The role of ClC-7 in maintaining lysosomal pH has been controversial. In this paper, we performed clinical and genetic evaluations of two children of different ethnicities. Both children had delayed myelination and development, organomegaly, and hypopigmentation, but neither had osteopetrosis. Whole-exome and -genome sequencing revealed a de novo c.2144A>G variant in CLCN7 in both affected children. This p.Tyr715Cys variant, located in the C-terminal domain of ClC-7, resulted in increased outward currents when it was heterologously expressed in Xenopus oocytes. Fibroblasts from probands displayed a lysosomal pH approximately 0.2 units lower than that of control cells, and treatment with chloroquine normalized the pH. Primary fibroblasts from both probands also exhibited markedly enlarged intracellular vacuoles; this finding was recapitulated by the overexpression of human p.Tyr715Cys CLCN7 in control fibroblasts, reflecting the dominant, gain-of-function nature of the variant. A mouse harboring the knock-in Clcn7 variant exhibited hypopigmentation, hepatomegaly resulting from abnormal storage, and enlarged vacuoles in cultured fibroblasts. Our results show that p.Tyr715Cys is a gain-of-function CLCN7 variant associated with developmental delay, organomegaly, and hypopigmentation resulting from lysosomal hyperacidity, abnormal storage, and enlarged intracellular vacuoles. Our data supports the hypothesis that the ClC-7 antiporter plays a critical role in maintaining lysosomal pH. Published by Elsevier Inc.

Entities:  

Keywords:  ClC-7 antiporter; chloroquine; cutaneous albinism; lysosomal hyperacidity; lysosomal membrane counterion; lysosomal pH; lysosomal storage disease; oculocutaneous albinism

Year:  2019        PMID: 31155284      PMCID: PMC6562152          DOI: 10.1016/j.ajhg.2019.04.008

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells.

Authors:  J Ancans; D J Tobin; M J Hoogduijn; N P Smit; K Wakamatsu; A J Thody
Journal:  Exp Cell Res       Date:  2001-08-01       Impact factor: 3.905

2.  Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.

Authors:  E R Liman; J Tytgat; P Hess
Journal:  Neuron       Date:  1992-11       Impact factor: 17.173

3.  A chloride channel widely expressed in epithelial and non-epithelial cells.

Authors:  A Thiemann; S Gründer; M Pusch; T J Jentsch
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

4.  Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human.

Authors:  Nader Chalhoub; Nadia Benachenhou; Venkatesh Rajapurohitam; Monica Pata; Mathieu Ferron; Annalisa Frattini; Anna Villa; Jean Vacher
Journal:  Nat Med       Date:  2003-03-10       Impact factor: 53.440

5.  Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

Authors:  U Kornak; D Kasper; M R Bösl; E Kaiser; M Schweizer; A Schulz; W Friedrich; G Delling; T J Jentsch
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

6.  Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.

Authors:  E Cleiren; O Bénichou; E Van Hul; J Gram; J Bollerslev; F R Singer; K Beaverson; A Aledo; M P Whyte; T Yoneyama; M C deVernejoul; W Van Hul
Journal:  Hum Mol Genet       Date:  2001-12-01       Impact factor: 6.150

7.  Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus.

Authors:  S M Stobrawa; T Breiderhoff; S Takamori; D Engel; M Schweizer; A A Zdebik; M R Bösl; K Ruether; H Jahn; A Draguhn; R Jahn; T J Jentsch
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

8.  The chloride channel ClC-4 co-localizes with cystic fibrosis transmembrane conductance regulator and may mediate chloride flux across the apical membrane of intestinal epithelia.

Authors:  Raha Mohammad-Panah; Cameron Ackerley; Johanna Rommens; Monideepa Choudhury; Yanchun Wang; Christine E Bear
Journal:  J Biol Chem       Date:  2001-10-23       Impact factor: 5.157

9.  Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.

Authors:  Dagmar Kasper; Rosa Planells-Cases; Jens C Fuhrmann; Olaf Scheel; Oliver Zeitz; Klaus Ruether; Anja Schmitt; Mallorie Poët; Robert Steinfeld; Michaela Schweizer; Uwe Kornak; Thomas J Jentsch
Journal:  EMBO J       Date:  2005-02-10       Impact factor: 11.598

10.  A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology.

Authors:  Toshio Kuronita; Eeva-Liisa Eskelinen; Hideaki Fujita; Paul Saftig; Masaru Himeno; Yoshitaka Tanaka
Journal:  J Cell Sci       Date:  2002-11-01       Impact factor: 5.285

View more
  22 in total

1.  West Syndrome Caused By a Chloride/Proton Exchange-Uncoupling CLCN6 Mutation Related to Autophagic-Lysosomal Dysfunction.

Authors:  Hailan He; Xiaoshuang Cao; Fei Yin; Tenghui Wu; Tobias Stauber; Jing Peng
Journal:  Mol Neurobiol       Date:  2021-02-16       Impact factor: 5.590

2.  Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes.

Authors:  Meiqin Hu; Ping Li; Ce Wang; Xinghua Feng; Qi Geng; Wei Chen; Matangi Marthi; Wenlong Zhang; Chenlang Gao; Whitney Reid; Joel Swanson; Wanlu Du; Richard I Hume; Haoxing Xu
Journal:  Cell       Date:  2022-06-23       Impact factor: 66.850

3.  Autosomal dominant osteopetrosis type II resulting from a de novo mutation in the CLCN7 gene: A case report.

Authors:  Xiu-Li Song; Li-Yuan Peng; Dao-Wen Wang; Hong Wang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

4.  Tonic inhibition of the chloride/proton antiporter ClC-7 by PI(3,5)P2 is crucial for lysosomal pH maintenance.

Authors:  Xavier Leray; Jacob K Hilton; Kamsi Nwangwu; Alissa Becerril; Vedrana Mikusevic; Gabriel Fitzgerald; Anowarul Amin; Mary R Weston; Joseph A Mindell
Journal:  Elife       Date:  2022-06-07       Impact factor: 8.713

5.  A Recurrent Gain-of-Function Mutation in CLCN6, Encoding the ClC-6 Cl-/H+-Exchanger, Causes Early-Onset Neurodegeneration.

Authors:  Maya M Polovitskaya; Carlo Barbini; Diego Martinelli; Frederike L Harms; F Sessions Cole; Paolo Calligari; Gianfranco Bocchinfuso; Lorenzo Stella; Andrea Ciolfi; Marcello Niceta; Teresa Rizza; Marwan Shinawi; Kathleen Sisco; Jessika Johannsen; Jonas Denecke; Rosalba Carrozzo; Daniel J Wegner; Kerstin Kutsche; Marco Tartaglia; Thomas J Jentsch
Journal:  Am J Hum Genet       Date:  2020-11-19       Impact factor: 11.025

6.  The 2019 FASEB Science Research Conference on Ion Channel Regulation: Molecules to Disease, July 7-12, 2019, Lisbon, Portugal.

Authors:  Henry M Colecraft; Rajesh Khanna
Journal:  FASEB J       Date:  2020-03-11       Impact factor: 5.191

Review 7.  From Pinocytosis to Methuosis-Fluid Consumption as a Risk Factor for Cell Death.

Authors:  Markus Ritter; Nikolaus Bresgen; Hubert H Kerschbaum
Journal:  Front Cell Dev Biol       Date:  2021-06-23

8.  Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders.

Authors:  Anna R Duncan; Maya M Polovitskaya; Héctor Gaitán-Peñas; Sara Bertelli; Grace E VanNoy; Patricia E Grant; Anne O'Donnell-Luria; Zaheer Valivullah; Alysia Kern Lovgren; Elaina M England; Emanuele Agolini; Jill A Madden; Klaus Schmitz-Abe; Amy Kritzer; Pamela Hawley; Antonio Novelli; Paolo Alfieri; Giovanna Stefania Colafati; Dagmar Wieczorek; Konrad Platzer; Johannes Luppe; Margarete Koch-Hogrebe; Rami Abou Jamra; Juanita Neira-Fresneda; Anna Lehman; Cornelius F Boerkoel; Kimberly Seath; Lorne Clarke; Yvette van Ierland; Emanuela Argilli; Elliott H Sherr; Andrea Maiorana; Thilo Diel; Maja Hempel; Tatjana Bierhals; Raúl Estévez; Thomas J Jentsch; Michael Pusch; Pankaj B Agrawal
Journal:  Am J Hum Genet       Date:  2021-06-28       Impact factor: 11.043

9.  Cryo-EM structure of the lysosomal chloride-proton exchanger CLC-7 in complex with OSTM1.

Authors:  Marina Schrecker; Julia Korobenko; Richard K Hite
Journal:  Elife       Date:  2020-08-04       Impact factor: 8.140

10.  Uncoupling endosomal CLC chloride/proton exchange causes severe neurodegeneration.

Authors:  Niclas Gimber; Dorothea Deuschel; Till Stuhlmann; Dmytro Puchkov; Gaia Novarino; Stefanie Weinert; Zohreh Farsi; Carmen F Ludwig; Karen I López-Cayuqueo; Rosa Planells-Cases; Thomas J Jentsch
Journal:  EMBO J       Date:  2020-03-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.